脑脊液
生物
特征(语言学)
2019-20冠状病毒爆发
医学
病毒学
免疫学
2019年冠状病毒病(COVID-19)
病理
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
神经科学
疾病
传染病(医学专业)
语言学
爆发
哲学
作者
Michael Heming,Xiaolin Li,Saskia Räuber,Anne K. Mausberg,Anna‐Lena Börsch,Maike Hartlehnert,Arpita Singhal,I‐Na Lu,Michael Fleischer,Fabian Szepanowski,Oliver Witzke,Thorsten Brenner,Ulf Dittmer,Nir Yosef,Christoph Kleinschnitz,Heinz Wiendl,Mark Stettner,Gerd Meyer zu Hörste
出处
期刊:Immunity
[Cell Press]
日期:2020-12-23
卷期号:54 (1): 164-175.e6
被引量:164
标识
DOI:10.1016/j.immuni.2020.12.011
摘要
Patients suffering from Coronavirus disease 2019 (COVID-19) can develop neurological sequelae, such as headache and neuroinflammatory or cerebrovascular disease. These conditions-termed here as Neuro-COVID-are more frequent in patients with severe COVID-19. To understand the etiology of these neurological sequelae, we utilized single-cell sequencing and examined the immune cell profiles from the cerebrospinal fluid (CSF) of Neuro-COVID patients compared with patients with non-inflammatory and autoimmune neurological diseases or with viral encephalitis. The CSF of Neuro-COVID patients exhibited an expansion of dedifferentiated monocytes and of exhausted CD4+ T cells. Neuro-COVID CSF leukocytes featured an enriched interferon signature; however, this was less pronounced than in viral encephalitis. Repertoire analysis revealed broad clonal T cell expansion and curtailed interferon response in severe compared with mild Neuro-COVID patients. Collectively, our findings document the CSF immune compartment in Neuro-COVID patients and suggest compromised antiviral responses in this setting.
科研通智能强力驱动
Strongly Powered by AbleSci AI